Vaccines for Cancer Prevention/HPV-Associated Cancers
Objectives and Strategies
Objective: Increase the percentage of adolescents 13 to 17 years of age who are upto-date with human papillomavirus (HPV) vaccine, especially among groups experiencing disproportionate effects residing in non-metropolitan (rural) areas of the state, from 58.2% to 70% in 2025 and 80% in 2030 (baseline: 2018 National Immunization Survey – Teen Survey).
Objective: Increase the percentage of young adults 18 to 26 years of age who are up-to-date with HPV vaccine from 25.1% to 50% in 2025 and 80% in 2030 (baseline: 2018 National Center for Health Statistics).
Objective: By 2030, decrease the HPV-associated cancer incidence rate in Appalachian Ohio (14.3 per 100,000) to the rate in non-Appalachian Ohio (12.4 per 100,000) to eliminate the disparity between Appalachian and non-Appalachian Ohio (baseline: 2017 OCISS).
Contact Us - Vaccines for Cancer Prevention Workgroup
We Always Welcome New Members
Together, we can achieve more. New members and fresh ideas are always welcome! OPCC will achieve far greater success than could be accomplished by individual organizations working alone.
